Pioneering Test Reliably Predicts the Spread or Return of Deadly Skin Cancer
AMBLor®, a new test from Newcastle University, accurately assesses the risk of early-stage melanomas spreading, enabling tailored patient management and reducing follow-up visits. A pioneering…